AI assistant
QUEST DIAGNOSTICS INC — Director's Dealing 2026
Feb 20, 2026
30275_dirs_2026-02-20_9cb02011-0f32-4696-8bbc-99f091cd6dce.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: QUEST DIAGNOSTICS INC (DGX)
CIK: 0001022079
Period of Report: 2026-02-18
Reporting Person: DELANEY MARK E (SVP & Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-18 | Common Stock | A | 1586 | — | Acquired | 9116 | Direct |
| 2026-02-18 | Common Stock | F | 205 | $210.01 | Disposed | 8911 | Direct |
| 2026-02-18 | Common Stock | F | 230 | $206.99 | Disposed | 8681 | Direct |
| 2026-01-28 | Common Stock | L | 15 | $183.51 | Acquired | 8696 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2026-02-18 | Non-Qualifed Stock Option (right to buy) | $204.96 | A | 7332 | Acquired | 2036-02-18 | Common Stock (7332) | Direct |
Footnotes
F1: Represents an award of restricted stock units.
F2: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.
F3: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.
F4: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.